Jie Tan

Also affiliated with Wuhan Union Hospital

NeuroscienceMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Therapeutic targeting of FOS in mutant TERT cancers through removing TERT suppression of apoptosis via regulating survivin and TRAIL-R2”.

Therapeutic targeting of FOS in mutant TERT cancers through removing TERT suppression of apoptosis via regulating survivin and TRAIL-R2

Proceedings of the National Academy of Sciences(2021)10.1073/pnas.2022779118

N/A

0.587DataRank · unranked

49 citations

Jie Tan, Xiaopei Shen, Ke Jiang, Chaoqun Wang, Guangwu Zhu +2 more

TERT promoter mutation determines apoptotic and therapeutic responses of BRAF -mutant cancers to BRAF and MEK inhibitors: Achilles Heel

Proceedings of the National Academy of Sciences(2020)10.1073/pnas.2004707117

N/A

0DataRank · unranked

45 citations

Rengyun Liu, Guangwu Zhu, Christopher B. Umbricht, Mingzhao Xing, Jie Tan

Genetic trio of BRAF and TERT alterations and rs2853669TT in papillary thyroid cancer aggressiveness

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad265

N/A

0DataRank · unranked

13 citations

Guangwu Zhu, Jie Tan, Xiaopei Shen, Mingzhao Xing, Rengyun Liu

The genetic duet of concurrent RASAL1 and PTEN alterations promotes cancer aggressiveness by cooperatively activating the PI3K–AKT pathway

Molecular Oncology(2024)10.1002/1878-0261.13701

N/A

0DataRank · unranked

7 citations

Jie Tan, Rengyun Liu, Guangwu Zhu, Lisa M. Rooper, Mingzhao Xing +1 more